Getting PCD Pharma Franchise Monopoly Basis is now easier than ever, thanks to Saphnix Medicure. We always believe in building a good relationship with our franchise owners and going the extra mile to keep them happy and satisfied with their work. See what one of our franchise owners says.
"As a Pharma franchisee, I made the best decision of my life by choosing Saphnix Medicure's PCD Pharma Franchise; they have all the factors that a Pharma Franchise company should possess; effective products, market demand, a good reputation, and good behaviour towards franchisees! The best pharma franchise in India! Lovely experience."
Salient features:
* 24*7 Support
* WHO, GMP Certified Company
* 400 + Products
* Dispatch within 24 hrs
I know what you are thinking. How to get in touch, right?
Give us a call or email.
So what are you waiting for?
PCD pharma franchise on monopoly basis has become one of the most prominent demands of franchise owners for running their business smoothly and efficiently. Essentially, a Pharmaceutical Franchise/PCD is a contract under which a pharma company grants a pharma professional or distributor, or a group of professionals or distributors, marketing and distribution rights to use their brand name, company name, and other commercial activities on behalf of the company on a monopoly basis. We offer you our franchise on a monopoly basis and give you a chance to earn like never before; in this blog, we will embark on our monopoly pharma franchise and its potential benefits.
Benefits of Monopoly pharma franchise
Getting a Pharma Franchise on a monopoly basis has many benefits for you, right from competition to ROI and sales or even reputation; you win in everything. So let us point out a few benefits of availing of Saphnix Medicure’s PCD pharma franchise monopoly basis.
Contact Saphnix Medicure today.
Call us :- +91 70567 56400
Visit: https://saphnixmedicure.com/pcd-pharma-franchise-monopoly-basis/
Adults are usually dependent on medicines suffering from problems like diabetes, high blood pressure, hypothyroid, etc.
There are two types of medication available generic and branded; the only difference between them is the price else they are exactly the same in composition, dosage, use, effects, side effects, route of administration, risks, safety, and strength.It is usually assumed that generic medicine being cheap might not be effective as compared to branded drugs.
People do doubt on the quality of the generic medicine, but the fact is that generic medicines are equally effective as branded due to the same composition of salts.They are cheap because the manufacturer does not spend a fortune of money on advertising it and has not invested time and money in research and development of that particular medicine.
When a brand introduces a medicine in the market, it does all the research, advertising and marketing required bringing its sales up, which makes it an expensive choice.Smart strategies are adopted to commence manufacturing of the generic ones.
Various myths are floating in the market as follows:-Generic drugs are manufactured poorly in quality.All the medicines are FDA approved; thus, they have to surpass the quality check guidelines.Genetic medicine takes a long time to show results.Again the same fact, FDA confirms generic drugs are fast and effective as the brand-name products.Generic medicines may differ in color, flavor, or appearance due to the trademark laws under which no one can imitate medicine's exact look.
If you have trust in generic drugs and are on a tight budget, you may go with generic medicines, and if you don't trust generic and are willing to pay extra bucks for branded medicines that happily buy.
A Pharmaceutical Company constantly working to aid people with healthy & peaceful lifestyle.
HQM Pharmaceuticals is leading pharmaceutical company located in Mumbai, and supporting the mankind with affordable & superior quality pharmaceutical products.https://hqmpharma.in/
The global gastrointestinal therapeutics market size is expected to reach USD 65.1 billion by 2025, according to a new report by Grand View Research, Inc., registering a 6.6% CAGR during the forecast period.
Growing geriatric population prone to gastrointestinal indications is one of the key factors anticipated to contribute to market growth.
According to a report by WHO, colon cancer caused nearly 694,000 deaths in 2014.Growing geriatric population, especially in emerging economies, is expected to drive market growth over the coming years.
Furthermore, initiatives undertaken by the Centers for Disease Control and Prevention (CDC) to promote cancer screening nationwide is expected to boost market growth over the forecast period.
The Division of Cancer Prevention and Control (DCPC) supports National Colorectal Cancer Action Campaign (NCCCP) and provides funds to aid research studies and implement strategies to control colorectal cancer.
This increase in initiatives for screening is expected to fuel sales of therapeutics and present lucrative growth opportunities to the market.Further key findings from the report suggest:Based on product type, the branded drugs segment dominated in 2016 owing to high potency drugs such as biologics and proton pump inhibitors.
